Phase 3 Trial of Weekly Oral Islatravir–Lenacapavir for HIV-1 Treatment - Jürgen K. Rockstroh; Moti N. Ramgopal; Adrian Curran Fàbregas; Malcolm Hedgcock; Kimberly A. Workowski; Sylvie Ronot-Bregigeon; Isabel Cassetti; Cynthia Brinson; Samir K. Gupta; Chien-Ching Hung; Mark O’Reilly; Jihad Slim; et al. (New England Journal of Medicine, 2026)